Cheng-Yu Lin Selected Research

Cheng-Yu Lin Research Topics

Disease

15	Neoplasms (Cancer) 03/2024 - 12/2004
9	Inflammation (Inflammations) 03/2024 - 01/2013
7	Infections 12/2023 - 06/2017
6	Hepatocellular Carcinoma (Hepatoma) 05/2021 - 03/2016
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2019
3	Obstructive Sleep Apnea 10/2022 - 01/2020
3	Fibrosis (Cirrhosis) 01/2022 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2018 - 11/2012
2	Pneumonia (Pneumonitis) 03/2024 - 01/2020
2	Neoplasm Metastasis (Metastasis) 06/2021 - 01/2015
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2021 - 05/2020
2	Sleep Apnea Syndromes (Sleep Apnea) 12/2020 - 11/2019
2	Noise-Induced Hearing Loss (Acoustic Trauma) 10/2010 - 11/2009
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2024
1	Bacteremia 12/2023
1	Dermatitis 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Acne Vulgaris 01/2023
1	Oropharyngeal Neoplasms 10/2022
1	Sleepiness 05/2022
1	Tinnitus 05/2022
1	Clostridium Infections 01/2022
1	Dysbiosis 01/2022
1	Snoring 01/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Adenocarcinoma 01/2021
1	Lung Injury 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2020
1	Sleep Wake Disorders 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2019
1	Out-of-Hospital Cardiac Arrest 10/2019
1	Osteoporosis 01/2019

Drug/Important Bio-Agent (IBA)

4	Phosphodiesterase 4 InhibitorsIBA 03/2024 - 03/2018
3	Protons (Proton)IBA 01/2021 - 10/2019
3	AmidesIBA 01/2021 - 10/2019
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2020 - 01/2019
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2024 - 03/2018
2	Rifabutin (Ansamycin)FDA Link 11/2023 - 07/2020
2	AntigensIBA 01/2023 - 10/2020
2	Indicators and Reagents (Reagents)IBA 12/2022 - 01/2018
2	BilirubinIBA 01/2022 - 11/2017
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
2	Gemcitabine FDA Link 06/2021 - 05/2020
2	Alkaline PhosphataseIBA 06/2021 - 05/2020
2	Imiquimod (Aldara)FDA LinkGeneric 01/2021 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 05/2020 - 01/2016
2	CilomilastIBA 01/2019 - 03/2018
2	Messenger RNA (mRNA)IBA 01/2018 - 09/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2017
2	Estrogen ReceptorsIBA 01/2018 - 09/2017
2	Metalloproteases (Metalloproteinases)IBA 01/2013 - 11/2012
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 11/2012
1	ribociclibIBA 03/2024
1	Cyclin-Dependent Kinase 4IBA 03/2024
1	Fusidic Acid (Fucithalmic)IBA 12/2023
1	RoflumilastIBA 12/2023
1	Therapeutic UsesIBA 11/2023
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	Penicillins (Penicillin)FDA Link 02/2023
1	Amoxicillin (Wymox)FDA LinkGeneric 02/2023
1	ChemokinesIBA 01/2023
1	CytokinesIBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	Liposomes (Liposome)IBA 01/2023
1	soyaethyl morpholiniumIBA 01/2023
1	Endopeptidase K (Proteinase K)IBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2022
1	Proton Pump InhibitorsIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022
1	AntibodiesIBA 01/2022
1	AcidsIBA 10/2021
1	Chimeric Antigen ReceptorsIBA 10/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020
1	Rheumatoid FactorIBA 01/2020
1	Complement C4 (Complement Component 4)IBA 01/2020
1	RolipramIBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 11/2019
1	Tumor Biomarkers (Tumor Markers)IBA 10/2019
1	APTIBA 10/2019
1	5,7-dimethoxy-1,4-phenanthrenequinoneIBA 02/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2019
1	Fetal Proteins (Fetoprotein)IBA 01/2019
1	Dexlansoprazole FDA Link 01/2019
1	LipidsIBA 01/2019

Therapy/Procedure

9	Therapeutics 01/2023 - 12/2004
3	Drug Therapy (Chemotherapy) 06/2021 - 01/2015
2	Liver Transplantation 05/2021 - 01/2019
2	Cardiopulmonary Resuscitation (CPR) 01/2020 - 10/2019
2	Hepatectomy 10/2019 - 11/2017
1	Free Tissue Flaps 10/2022
1	Nasal Surgical Procedures 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2020
1	Immunotherapy 10/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2020